[EN] RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS<br/>[FR] CONCEPTION RATIONNELLE DE MÉDICAMENTS CIBLANT DES INFECTIONS BACTÉRIENNES À GRAM NÉGATIF RÉSISTANT AUX ANTIBIOTIQUES DE LA FAMILLE DES POLYMYXINES
申请人:UNIV COLUMBIA
公开号:WO2017083859A1
公开(公告)日:2017-05-18
The present invention relates to identification of inhibitors or antagonists of aminoarabinase glycosyltransferase (ArnT) and their use in compositions, methods of treatment or prevention of drug resistant gram negative infections, or inhibiting the growth of gram negative bacterial infections resistant to polymyxin-class antibiotics. In certain aspects, the inhibitors or antagonists can be administered in combination with one or more antibacterial agents.